May 7, 2013 / 12:11 PM / 4 years ago

BRIEF-Baxter shares down after drug fails in late-stage trial

1 Min Read

NEW YORK, May 7 (Reuters) - Baxter International Inc : * Shares down 2.6 percent in premarket trade after alzeheimer's drug fail

late-stage trial

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below